Literature DB >> 27134622

Highly scalable, closed-loop synthesis of drug-loaded, layer-by-layer nanoparticles.

Santiago Correa1, Ki Young Choi2, Erik C Dreaden2, Kasper Renggli3, Aria Shi3, Li Gu2, Kevin E Shopsowitz2, Mohiuddin A Quadir2, Elana Ben-Akiva3, Paula T Hammond2.   

Abstract

Layer-by-layer (LbL) self-assembly is a versatile technique from which multicomponent and stimuli-responsive nanoscale drug carriers can be constructed. Despite the benefits of LbL assembly, the conventional synthetic approach for fabricating LbL nanoparticles requires numerous purification steps that limit scale, yield, efficiency, and potential for clinical translation. In this report, we describe a generalizable method for increasing throughput with LbL assembly by using highly scalable, closed-loop diafiltration to manage intermediate purification steps. This method facilitates highly controlled fabrication of diverse nanoscale LbL formulations smaller than 150 nm composed from solid-polymer, mesoporous silica, and liposomal vesicles. The technique allows for the deposition of a broad range of polyelectrolytes that included native polysaccharides, linear polypeptides, and synthetic polymers. We also explore the cytotoxicity, shelf life and long-term storage of LbL nanoparticles produced using this approach. We find that LbL coated systems can be reliably and rapidly produced: specifically, LbL-modified liposomes could be lyophilized, stored at room temperature, and reconstituted without compromising drug encapsulation or particle stability, thereby facilitating large scale applications. Overall, this report describes an accessible approach that significantly improves the throughput of nanoscale LbL drug-carriers that show low toxicity and are amenable to clinically relevant storage conditions.

Entities:  

Keywords:  biomaterials; colloid chemistry; layer-by-layer nanoparticles; polymer engineering; scalable synthesis

Year:  2016        PMID: 27134622      PMCID: PMC4847955          DOI: 10.1002/adfm.201504385

Source DB:  PubMed          Journal:  Adv Funct Mater        ISSN: 1616-301X            Impact factor:   18.808


  56 in total

1.  Hyaluronan forms specific stable tertiary structures in aqueous solution: a 13C NMR study.

Authors:  J E Scott; F Heatley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Multiplexed sensing of ions with barcoded polyelectrolyte capsules.

Authors:  Loretta L del Mercato; Azhar Z Abbasi; Markus Ochs; Wolfgang J Parak
Journal:  ACS Nano       Date:  2011-11-16       Impact factor: 15.881

3.  Encapsulation of water-insoluble drugs in polymer capsules prepared using mesoporous silica templates for intracellular drug delivery.

Authors:  Yajun Wang; Yan Yan; Jiwei Cui; Leticia Hosta-Rigau; Joan K Heath; Edouard C Nice; Frank Caruso
Journal:  Adv Mater       Date:  2010-10-08       Impact factor: 30.849

4.  Synthesis and characterization of ratiometric ion-sensitive polyelectrolyte capsules.

Authors:  Loretta L Del Mercato; Azhar Z Abbasi; Wolfgang J Parak
Journal:  Small       Date:  2010-12-22       Impact factor: 13.281

5.  Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.

Authors:  Ki Young Choi; Hong Yeol Yoon; Jong-Ho Kim; Sang Mun Bae; Rang-Woon Park; Young Mo Kang; In-San Kim; Ick Chan Kwon; Kuiwon Choi; Seo Young Jeong; Kwangmeyung Kim; Jae Hyung Park
Journal:  ACS Nano       Date:  2011-10-11       Impact factor: 15.881

6.  Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowing-electron microscopy and computer simulation. Hyaluronan is a very efficient network-forming polymer.

Authors:  J E Scott; C Cummings; A Brass; Y Chen
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

Review 7.  The folate receptor: what does it promise in tissue-targeted therapeutics?

Authors:  Marcela D'Alincourt Salazar; Manohar Ratnam
Journal:  Cancer Metastasis Rev       Date:  2007-03       Impact factor: 9.264

8.  Controlling in vivo stability and biodistribution in electrostatically assembled nanoparticles for systemic delivery.

Authors:  Zhiyong Poon; Jong Bum Lee; Stephen W Morton; Paula T Hammond
Journal:  Nano Lett       Date:  2011-04-27       Impact factor: 11.189

9.  Influence of salts on electrostatic interactions between poliovirus and membrane filters.

Authors:  P A Shields; S R Farrah
Journal:  Appl Environ Microbiol       Date:  1983-02       Impact factor: 4.792

10.  Physical characteristics of freeze-dried griseofulvin-lipids nanoparticles.

Authors:  Seitaro Kamiya; Yasuo Nozawa; Astuo Miyagishima; Takurou Kurita; Yasuyuki Sadzuka; Takashi Sonobe
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-02       Impact factor: 1.645

View more
  15 in total

1.  A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non-Small Cell Lung Cancer.

Authors:  Li Gu; Zhou J Deng; Sweta Roy; Paula T Hammond
Journal:  Clin Cancer Res       Date:  2017-09-14       Impact factor: 12.531

2.  Solution Conditions Tune and Optimize Loading of Therapeutic Polyelectrolytes into Layer-by-Layer Functionalized Liposomes.

Authors:  Santiago Correa; Natalie Boehnke; Elad Deiss-Yehiely; Paula T Hammond
Journal:  ACS Nano       Date:  2019-04-18       Impact factor: 15.881

3.  Stiffness of targeted layer-by-layer nanoparticles impacts elimination half-life, tumor accumulation, and tumor penetration.

Authors:  Stephanie M Kong; Daniel F Costa; Anna Jagielska; Krystyn J Van Vliet; Paula T Hammond
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-19       Impact factor: 11.205

4.  A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles.

Authors:  Joelle P Straehla; Cynthia Hajal; Hannah C Safford; Giovanni S Offeddu; Natalie Boehnke; Tamara G Dacoba; Jeffrey Wyckoff; Roger D Kamm; Paula T Hammond
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-01       Impact factor: 12.779

5.  Rational design of multistage drug delivery vehicles for pulmonary RNA interference therapy.

Authors:  A Sofia Silva; Kevin E Shopsowitz; Santiago Correa; Stephen W Morton; Erik C Dreaden; Teresa Casimiro; Ana Aguiar-Ricardo; Paula T Hammond
Journal:  Int J Pharm       Date:  2020-10-26       Impact factor: 5.875

6.  Cancer Cell Coating Nanoparticles for Optimal Tumor-Specific Cytokine Delivery.

Authors:  Antonio E Barberio; Sean G Smith; Santiago Correa; Cathy Nguyen; Bang Nhan; Mariane Melo; Talar Tokatlian; Heikyung Suh; Darrell J Irvine; Paula T Hammond
Journal:  ACS Nano       Date:  2020-09-05       Impact factor: 15.881

7.  Tuning Nanoparticle Interactions with Ovarian Cancer through Layer-by-Layer Modification of Surface Chemistry.

Authors:  Santiago Correa; Natalie Boehnke; Antonio E Barberio; Elad Deiss-Yehiely; Aria Shi; Benjamin Oberlton; Sean G Smith; Ioannis Zervantonakis; Erik C Dreaden; Paula T Hammond
Journal:  ACS Nano       Date:  2020-02-10       Impact factor: 15.881

8.  Binary Targeting of siRNA to Hematologic Cancer Cells In Vivo using Layer-by-Layer Nanoparticles.

Authors:  Ki Young Choi; Santiago Correa; Jouha Min; Jiahe Li; Sweta Roy; Kristiana H Laccetti; Erik Dreaden; Stephanie Kong; Roun Heo; Young Hoon Roh; Edward C Lawson; Peter A Palmer; Paula T Hammond
Journal:  Adv Funct Mater       Date:  2019-03-27       Impact factor: 18.808

9.  Electrostatic Conjugation of Nanoparticle Surfaces with Functional Peptide Motifs.

Authors:  Natalie Boehnke; Kate J Dolph; Valeria M Juarez; Julia M Lanoha; Paula T Hammond
Journal:  Bioconjug Chem       Date:  2020-08-11       Impact factor: 4.774

10.  Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-l-glutamic Acid-coated Layer-by-Layer Nanoparticles.

Authors:  Isidora Tošić; Lisa N Heppler; Susana P Egusquiaguirre; Natalie Boehnke; Santiago Correa; Daniel F Costa; Elizabeth A Grossman Moore; Sharmistha Pal; Douglas S Richardson; Alexander R Ivanov; Daphne A Haas-Kogan; Daniel K Nomura; Paula T Hammond; David A Frank
Journal:  Mol Cancer Ther       Date:  2021-02-03       Impact factor: 6.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.